William Polvino's most recent trade in SAB Biotherapeutics Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 15, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
SAB Biotherapeutics Inc | William J. Polvino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
SAB Biotherapeutics Inc | William J. Polvino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 13,958 | 13,958 | - | - | Stock Option (right to buy) | |
SAB Biotherapeutics Inc | William Polvino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 139,585 | 139,585 | - | - | Employee Stock Option (right to buy) | |
SAB Biotherapeutics Inc | William Polvino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 11,748 | 11,748 | - | - | Earnout Rights (Restricted Stock Units) |